EFFECTS OF NIGELLA SATIVA ON VARIOUS PARAMETERS IN PATIENTS OF NON-ALCOHOLIC FATTY LIVER DISEASE

Mazhar Hussain, Ali Gul Tunio, Lubna Akhtar Arain, Ghulam Serwar Shaikh

Abstract


Background: Non-alcoholic Fatty Liver disease (NAFLD) is the most common cause of progressive liver disorders worldwide. Drug options are limited with varying results. Nigella sativa in the form of herbal medicine could be another option because of its strong historical background. The objective of the study was to evaluate the effect Nigella sativa on various parameters in patients of NAFLD. Methods: A randomized controlled trial was conducted at outpatient clinic of medical unit-1 of Sheikh Zayed Medical College/Hospital, Rahim Yar Khan, in which seventy patients of NAFLD were divided in to interventional and non-interventional groups. The interventional group was given cap Nigella sativa 1g twice a day while non-interventional group was given cap placebo in a same way for three months. Body weight, BMI, liver enzymes and ultrasound finding of fatty liver were assayed before and after treatment. Results: After 12 weeks treatment with Nigella sativa body weight decreased significantly from 86±13.8 to76±12.6 kg vs placebo (p=0.041). BMI also reduced significantly from 29.06±4.6 to 26.25±6.2kg/m2 vs placebo(p=0.012). There is remarkable reduction in aminotransferases level after treatment with Nigella sativa vs placebo (ALT: 78.05±5.52 to 52.6±5.65 IU/L vs 76.48±4.95–74.32±5.58 IU/L (p=0.036). AST: 65.54±4.56–44.56±5.52 IU/L vs 63.25±5.43–59.43±3.39 IU/L (p=0.021). There was overall 57.14 % patient had normal fatty liver grading on ultrasound after 12 weeks treatment with Nigella sativa as compared to placebo (p=0.002). Conclusion: Nigella sativa improves bio chemical and fatty liver changes in NAFLD patients. Its use in early stages of NAFLD is recommended in order to prevent its life-threatening complication.

Keywords: NAFLD; Nigella sativa; Body weight; ALT; AST; Fatty liver grading


Full Text:

PDF

References


Ashtaris S, Pourhoseingholi MA, Zali MR. Non-alcoholic fatty liver disease in Asia: prevention and planning. World J Hepatol 2015;7(13):1788–96.

Petersen KF, Dufour S, Hariri A, Willaims CN, Foo JN, Zhang XM, et al. Apolipoprotein C3 gene variants in non alcoholic fatty liver disease. N Engl M J Med 2010;362(12):1082–9.

Mahady SE, George J. The future liver of the Asia pacific: fatter and firmer from more fructose and fortune? J Clin Exp Hepatol 2012;3(2):106–13.

Milic S, Lulic D, Stimac D. Non-alcoholic fatty liver disease and obesity: biochemical, metabolic and clinical presentations. World J Gastroenterol 2014;20(28):9330–7.

Hashimoto E, Tanjgi M, Tokusghige K. Characteristics and diagnosis of NAFLD/NASH. J Gastroenterol Hepatol 2013;28(4):64–70.

Bee Goh GB, Dasarathy S, McCullough A. Pharmacological management of non-alcoholic fatty liver disease: review. Adv Pharmacoepidemiol Drug Saf 2014;3(3):1000157.

Chikezie PC, Ojiako OA. Herbal Medicine: Yesterday, Today and Tomorrow. Altern Integr Med 2015: 4: 195.

Hussain DA, Hussain MM. Nigella sativa (black seed) is an effective herbal remedy for every disease except death- a Prophetic statement which modern scientists confirm unanimously:a review. Adv Med Plant Res 2016;4(2):27–57.

Ahmad A, Husain A, Mujeeb M, Khan SA, Najmi AK, Siddique NA, et al. A rivew on therapeutic potential of Nigella sativa : a miracle herb. Asian Pac J Trop Biomed 2013;3(5):337–52.

Ibrahim RM, Hamdan NS, Ismail M, Saini SM, Abdrashid SN, Abdul Latiff L, et al. Protective effect of Nigella sativa on metabolic syndrome in menopausal women. Adv Pharm Bull 2014;4(1):29–33.

Fallah Huseini H, Amini M, Mohtashami R, Ghamarchehre ME, Sadeqhi Z, Kianbakht S, et al. Blood pressure lowering effect of Nigella sativa L. seed oil in healthy volunteers: a randomized double blind placebo controlled trial. Phytother Res 2013;27(12):1849–53.

Heshmati J, Namazi N, Memarzadeh MR, Taghizadeh M, Kolahdooz F. Nigella sativa oil effects glucose metabolism and lipid concentration in patients with type 2 diabetes: A randomized double blind placebo control trial. Food Res Int 2015;70:87–93.

Tasawar Z, Siraj Z, Ahmad N, Lashari MH. The effect of Nigella sativa (kalonji) on lipid profiles in patients with stable coronary artery disease in Multan, Pakistan. Pak J Nutr 2011;10(2):162–7.

Mollazadeh H, Hosseinzadeh H. The protective effect of Nigella sativa against liver injure: a review. Iran J Basic Med Sci 2104;17(12):958–66.

Takaki A, Kawai D, Yamamoto K. Multiple hits including oxidative stress as pathogenesis and treatment target in non-alcoholic steatohepatotis (NASH). Int J Mol Sci 2013;14(10):20704–28.

Dasarathy S, Dasarathy J, Khiyami A, Joseph R, Lopez R, Mccullough AJ. Validity of real time ultrasound in the diagnosis of hepatic steatosis: a prospective study. J Hepatol 2009;51(6):1061–7.

Promrat K, Kleiner DE, Niemeier HM, Jackvony E, Kearns M, Wands JR, et al. Randomized controlled trial testing the effect of weight loss on non-alcoholic steatohepatitis. Hepatology 2010;51(1):121–9.

Vilar-Gomez E, Martinez-Perez Y, Calzadilla-Berot L, Toeers-Gonzalez A, Gar-Oramas B, Gonzalez-Fabian L, et al. Weight loss through lifestyle modification significantly reduces features of non-alcoholic steatohepatitis. Gastroenterology 2015;149(2):367–78.

Didi A, Meziane RK, Amamou F, Benhmidat A, Sari DC. Metabolic and antioxidant effects of Nigella sativa oil on prevention of obesity development in rats feed high fat diet. Eur Chem Bull 2014;3(9):888–96.

Le PM, Benhaddou-Andaloussi A, Elimadi A, Settaf A, Cherrah Y, Haddad PS. The petroleum ether extract of Nigella sativa exerts lipid lowering and insulin sensitizing actions in rat. J Ethnopharmacol 2004;94(2-3):251–9.

Aller R, Izaola O, Gomez S, Tafur C, Gonzalez G, Berroa E, et al. Effect of silymarin plus vitamin E in patients with non-alcoholic fatty liver disease. A randomized clinical pilot study. Eur Rev Med Pharmacol Sci 2015;19(16):3118–24.

Al-Okbi SY, Mohamed DA, Hamed TE, Edris AE. Potential protective effect of Nigella sativa crude oils towards fatty liver in rats. Eur J Lipid Sci Technol 2013;115(7):774–82.

Awad AS, Abd Al Haleem EN, EL-Bakly WM, Sherief MA. Thymoquinone alleviates non-alcoholic fatty liver disease in rats via suppression of oxidative stress, inflammation, apoptosis. Naunyn schmiedebergs Arch Pharmacol 2016;389(4):381–91.

Hasan MN, Khan RA, Nasiruddin M, Khan AA. Protective effect of Nigella sativa against paracetamol induced hepatic and renal damages. Int J Basic Clin Pharmacol 2015;4(3):503–9.

Mudie K, Seifu D, Challa F, Abebe A, Debella A, Gebregzabher A. Hepatoprotective activity of aqueous seed extract of Nigella sativa against highly active antiretroviral therapy induced hepatotoxicity in rats. Pharmacol Online 2014;3:11–21.

Jaswal A, Shukla S. Therapeutic efficacy of Nigella sativa linn seed extract against CCl4 induced hepatic injury in wistar rats. Indian J Exp Biol 2015;53(1):44–50.

Develi S, Evran B, Betul Kalaz E, Kocak-Toker N, Erata GO. Protective effect of Nigella sativa oil against binge ethanol induced oxidative stress and liver injury in rats. Chin J Nat Med 2014;12(7):495–9.

Prabhakar P, Reeta KH, Maulik SK, Dinda AK, Gupta YK. Protective effect of thymoquinone against high fructose induced metabolic syndrome in rats. Eur J Nutr 2015;54(7):1117–27.

Mohamed WS, Mostafa AM, Mohamed KM, Serwah AH. Effects of fenugreek, Nigella and termis seeds in non-alcoholic fatty liver in obese diabetic albino rats. Arab J Gastroenterol 2015;16(1):1–9.

Najmi A, Nasiruddin M, Khan RA, Haque SF. Therapeutic effect of Nigella saliva in patients of poor glycemic control. Asian J Pharm Clin Res 2012;5(3):224–8.

Khan S, Shah AS, Rahim H, Gillani FM, Chisti KA, Shah M, et al. Effect of Nigella sativa tablets on various parameters of insulin resistance syndrome in fatty liver disease in Peshawar cantonment. Am Eurasian J Toxicol Sci 2015;7(4):243–6.

Hernaez R, Lazo M, Bonekamp S, Kamel I, Brancati FL, Guallar E, et al. Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis. Hepatology 2011;54(3):1082–90.


Refbacks

  • There are currently no refbacks.


Contact Number: +92-992-382571

email: [jamc] [@] [ayubmed.edu.pk]